The improvement seen in glycemic control could not be due to enhanced endogenous insulin secretion, since post-meal C-peptide levels remained undetectable after sitagliptin treatment, but it could be a result of other factors (for example, suppression of glucagon levels)
Singh S, Dulai PS (2022) Ulcerative colitis: clinical manifestations and management
With the introduction of an individualized approach to the management of patients with T2D, the potential value of glucose-lowering therapy involves more than a costbenefit analysis, and is based on a package of attributes that take into account long-term safety, tolerability, risk of hypoglycemia and weight gain, and suitability in the presence of comorbidities and other medications
Draw the Diluent: Using a sterile syringe, pull back your desired amount of bacteriostatic water
In the event we fail in this promise, we will give you the option of a full refund for the current month's membership payment or a credit to your account
How should Semaglutide be administered for effective weight loss